by ADRIAN FREDERICK MANZ Manz | Oct 27, 2025 | The Doctor's Dose
Nvidia Stock Poised for New Record as AI Boom Fuels Investor Optimism Nvidia Nears Record as Earnings Week Takes Center Stage NVDA is edging toward an all-time high as Wall Street braces for Big Tech earnings and another wave of AI capex. Nvidia shares climbed...
by ADRIAN FREDERICK MANZ Manz | Oct 26, 2025 | The Doctor's Dose
Fed Poised to End Quantitative Tightening: What It Means for Banks, Markets, and Traders The Federal Reserve is widely expected to end quantitative tightening (QT) this week—concluding a three-year balance-sheet runoff that has drained more than $2 trillion in...
by ADRIAN FREDERICK MANZ Manz | Oct 25, 2025 | The Doctor's Dose
Inside Sam Altman’s $1.5 Trillion AI Deals: How OpenAI Rewrote the Rules of Tech Negotiation Sam Altman, the CEO of OpenAI, has taken an unprecedented approach to corporate dealmaking—personally spearheading partnerships worth as much as $1.5 trillion with chip and...
by ADRIAN FREDERICK MANZ Manz | Oct 25, 2025 | The Doctor's Dose
Nvidia Invests $1 Billion in Nokia to Bring AI to Telecom Networks Nokia’s Comeback Fueled by AI Nvidia is investing $1 billion in Nokia, acquiring a 2.9% stake in the Finnish telecoms giant as part of a broad alliance to integrate artificial intelligence into the...
by ADRIAN FREDERICK MANZ Manz | Oct 24, 2025 | The Doctor's Dose
Mortgage Rates and Home Prices Are Changing — How to Get Ready By Shaina Mishkin | October 23, 2025 | Focus keyphrase: Mortgage rates and home prices Housing costs in the U.S. are set to stabilize — but not because of the deep price declines or sharp drops in mortgage...
by ADRIAN FREDERICK MANZ Manz | Oct 24, 2025 | The Doctor's Dose
OpenAI’s Ownership Shake-Up: $500B Valuation, $1T Build-Out, and What It Means for Investors TraderInsight • October 2025 OpenAI just became the world’s most valuable private company at a $500 billion valuation, even as it pursues an unprecedented plan to deploy $1...
by ADRIAN FREDERICK MANZ Manz | Oct 23, 2025 | The Doctor's Dose
Investors Brace for US and UK Inflation Data as Markets Await Direction After weeks of uncertainty caused by the U.S. government shutdown, investors will finally get a clearer picture of how the Trump administration’s trade war has filtered through to consumer prices....
by ADRIAN FREDERICK MANZ Manz | Oct 22, 2025 | The Doctor's Dose
New Advances in Triple Negative Breast Cancer Treatment Offer Hope for Patients Major pharmaceutical companies AstraZeneca, Daiichi Sankyo, and Gilead have unveiled promising trial results that could transform the outlook for patients with triple-negative breast...
by ADRIAN FREDERICK MANZ Manz | Oct 21, 2025 | The Doctor's Dose
Rare Earth Stocks Erupt as U.S. Pushes to Break China’s Grip TraderInsight • October 19, 2025 Investors are racing to back producers of rare earths and other critical minerals as Washington moves to loosen China’s stranglehold on key inputs for smartphones, EVs, and...
by ADRIAN FREDERICK MANZ Manz | Oct 21, 2025 | The Doctor's Dose
Apple’s iPhone 17 Ignites Growth Ahead of Holiday Season By TraderInsight Editorial Team | October 20, 2025 The launch of the Apple iPhone 17 is fueling the company’s strongest smartphone growth since the Covid-19 boom, driven by its bold redesign, upgraded cameras,...
